Umoja
formerly Umoja BiopharmaPioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
Seattle, United States · Founded 2019 · $363.0M raised
- Headquarters
- Seattle, Washington
- Employees
- 201–500
- Founded
- 2019
- Business Model
- B2B
- Website
- umojabiopharma.com
- Total Funding
- $363.0M
- Last Round
- $100.0M Series CJan 2025
- Rounds
- 4
About
Umoja Biopharma is a clinical-stage biotechnology company pioneering in vivo CAR T cell therapy. Rather than manufacturing CAR T cells outside the body, Umoja's proprietary platform reprograms T cells inside patients, eliminating the costly and time-consuming ex vivo manufacturing process. The company's integrated technology platform is designed to make next-generation immunotherapy cost-effectively accessible to all cancer patients, including those who cannot benefit from current CAR T treatments. Umoja's pipeline targets solid tumors and hematologic malignancies.
Summary
Umoja is a Biotech company based in Seattle, United States, founded in 2019. It has raised $363.0M in total across 4 rounds, most recently a $100.0M Series C round in Jan 2025. Investors include DCVC (Data Collab), Cormorant Asset Management and MPM Capital.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2025
Sign up to see all 4 rounds
Seed through Series C — per-round amounts, valuations, and who invested in each round.
Investors
DCVC (Data Collab)
3 rounds
Cormorant Asset Management
2 rounds
MPM Capital
2 rounds
Double Point Ventures
1 round
.png)
SoftBank
1 round
Qiming Venture Partners USA
1 round
RTW Investments
1 round
Alexandria Venture Investments
1 round
ARK Invest
1 round
Perceptive Advisors
1 round
Vivo Capital
1 round
Acuta Capital Partners
1 round
Deerfield Management
1 round
TCGX
1 round
Similar Companies
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/umoja"><img src="https://indexed.vc/api/badge/company/umoja" alt="Umoja on Indexed.vc" width="260" height="76" /></a>